Literature DB >> 15868399

Regulation of poly(ADP-ribose) metabolism by poly(ADP-ribose) glycohydrolase: where and when?

M-E Bonicalzi1, J-F Haince, A Droit, G G Poirier.   

Abstract

Poly(ADP-ribose) glycohydrolase (PARG) is a catabolic enzyme that cleaves ADP-ribose polymers formed by members of the PARP family of enzymes. Despite its discovery and subsequent partial purification in the 1970s and the cloning of its single gene in the late 1990s, little is known about the role of PARG in cell function. Because of its low abundance within cells and its extreme sensitivity to proteases, PARG has been difficult to study. The existence of several PARG isoforms with different subcellular localizations is still debated today after more than 30 years of intensive research. In this article, we want to summarize and discuss the current knowledge related to PARG, its different forms and subcellular distribution. We also examine the possible biological roles of PARG in modulating chromatin structure, transcription, DNA repair and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15868399     DOI: 10.1007/s00018-004-4505-1

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  32 in total

Review 1.  A systematic review and meta-analysis on the therapeutic equivalence of statins.

Authors:  T-C Weng; Y-H Kao Yang; S-J Lin; S-H Tai
Journal:  J Clin Pharm Ther       Date:  2010-04       Impact factor: 2.512

2.  European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: practical guidance for use in patients at very high cardiovascular risk.

Authors:  Ulf Landmesser; M. John Chapman; Michel Farnier; Baris Gencer; Stephan Gielen; G Kees Hovingh; Thomas F Lüscher; David Sinning; Lale Tokgözoglu; Olov Wiklund; Jose Luis Zamorano; Fausto J Pinto; Alberico L Catapano
Journal:  Eur Heart J       Date:  2017-08-01       Impact factor: 29.983

3.  ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

Authors:  Zeljko Reiner; Alberico L Catapano; Guy De Backer; Ian Graham; Marja-Riitta Taskinen; Olov Wiklund; Stefan Agewall; Eduardo Alegria; M John Chapman; Paul Durrington; Serap Erdine; Julian Halcox; Richard Hobbs; John Kjekshus; Pasquale Perrone Filardi; Gabriele Riccardi; Robert F Storey; David Wood
Journal:  Eur Heart J       Date:  2011-06-28       Impact factor: 29.983

Review 4.  Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement.

Authors:  Genovefa D Kolovou; Dimitri P Mikhailidis; Jan Kovar; Dennis Lairon; Børge G Nordestgaard; Teik Chye Ooi; Pablo Perez-Martinez; Helen Bilianou; Katherine Anagnostopoulou; George Panotopoulos
Journal:  Curr Vasc Pharmacol       Date:  2011-05       Impact factor: 2.719

5.  Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials.

Authors:  Jordan Fulcher; Rachel O'Connell; Merryn Voysey; Jonathan Emberson; Lisa Blackwell; Borislava Mihaylova; John Simes; Rory Collins; Adrienne Kirby; Helen Colhoun; Eugene Braunwald; John La Rosa; T R Pedersen; Andrew Tonkin; Barry Davis; Peter Sleight; Maria Grazia Franzosi; Colin Baigent; Anthony Keech
Journal:  Lancet       Date:  2015-01-09       Impact factor: 79.321

6.  Cardiovascular disease in Europe--epidemiological update 2015.

Authors:  Nick Townsend; Melanie Nichols; Peter Scarborough; Mike Rayner
Journal:  Eur Heart J       Date:  2015-08-25       Impact factor: 29.983

Review 7.  Targeting PCSK9 for hypercholesterolemia.

Authors:  Giuseppe Danilo Norata; Gianpaolo Tibolla; Alberico Luigi Catapano
Journal:  Annu Rev Pharmacol Toxicol       Date:  2013-10-16       Impact factor: 13.820

8.  2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).

Authors:  Massimo F Piepoli; Arno W Hoes; Stefan Agewall; Christian Albus; Carlos Brotons; Alberico L Catapano; Marie-Therese Cooney; Ugo Corrà; Bernard Cosyns; Christi Deaton; Ian Graham; Michael Stephen Hall; F D Richard Hobbs; Maja-Lisa Løchen; Herbert Löllgen; Pedro Marques-Vidal; Joep Perk; Eva Prescott; Josep Redon; Dimitrios J Richter; Naveed Sattar; Yvo Smulders; Monica Tiberi; H Bart van der Worp; Ineke van Dis; W M Monique Verschuren; Simone Binno
Journal:  Eur Heart J       Date:  2016-05-23       Impact factor: 29.983

9.  Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society.

Authors:  Børge G Nordestgaard; M John Chapman; Steve E Humphries; Henry N Ginsberg; Luis Masana; Olivier S Descamps; Olov Wiklund; Robert A Hegele; Frederick J Raal; Joep C Defesche; Albert Wiegman; Raul D Santos; Gerald F Watts; Klaus G Parhofer; G Kees Hovingh; Petri T Kovanen; Catherine Boileau; Maurizio Averna; Jan Borén; Eric Bruckert; Alberico L Catapano; Jan Albert Kuivenhoven; Päivi Pajukanta; Kausik Ray; Anton F H Stalenhoef; Erik Stroes; Marja-Riitta Taskinen; Anne Tybjærg-Hansen
Journal:  Eur Heart J       Date:  2013-08-15       Impact factor: 29.983

10.  Explaining the decrease in U.S. deaths from coronary disease, 1980-2000.

Authors:  Earl S Ford; Umed A Ajani; Janet B Croft; Julia A Critchley; Darwin R Labarthe; Thomas E Kottke; Wayne H Giles; Simon Capewell
Journal:  N Engl J Med       Date:  2007-06-07       Impact factor: 91.245

View more
  46 in total

1.  The KRAS promoter responds to Myc-associated zinc finger and poly(ADP-ribose) polymerase 1 proteins, which recognize a critical quadruplex-forming GA-element.

Authors:  Susanna Cogoi; Manikandan Paramasivam; Alexandro Membrino; Kazunari K Yokoyama; Luigi E Xodo
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

2.  Proteomics analysis of Helicoverpa armigera single nucleocapsid nucleopolyhedrovirus identified two new occlusion-derived virus-associated proteins, HA44 and HA100.

Authors:  Fei Deng; Ranran Wang; Minggang Fang; Yue Jiang; Xushi Xu; Hanzhong Wang; Xinwen Chen; Basil M Arif; Lin Guo; Hualin Wang; Zhihong Hu
Journal:  J Virol       Date:  2007-06-20       Impact factor: 5.103

Review 3.  Functions of the poly(ADP-ribose) polymerase superfamily in plants.

Authors:  Rebecca S Lamb; Matteo Citarelli; Sachin Teotia
Journal:  Cell Mol Life Sci       Date:  2011-08-23       Impact factor: 9.261

4.  PARP1 inhibition alleviates injury in ARH3-deficient mice and human cells.

Authors:  Masato Mashimo; Xiangning Bu; Kazumasa Aoyama; Jiro Kato; Hiroko Ishiwata-Endo; Linda A Stevens; Atsushi Kasamatsu; Lynne A Wolfe; Camilo Toro; David Adams; Thomas Markello; William A Gahl; Joel Moss
Journal:  JCI Insight       Date:  2019-02-21

5.  ADP-ribosylhydrolase 3 (ARH3), not poly(ADP-ribose) glycohydrolase (PARG) isoforms, is responsible for degradation of mitochondrial matrix-associated poly(ADP-ribose).

Authors:  Marc Niere; Masato Mashimo; Line Agledal; Christian Dölle; Atsushi Kasamatsu; Jiro Kato; Joel Moss; Mathias Ziegler
Journal:  J Biol Chem       Date:  2012-03-20       Impact factor: 5.157

Review 6.  Transcriptional control by PARP-1: chromatin modulation, enhancer-binding, coregulation, and insulation.

Authors:  W Lee Kraus
Journal:  Curr Opin Cell Biol       Date:  2008-04-29       Impact factor: 8.382

7.  Investigation of PARP-1, PARP-2, and PARG interactomes by affinity-purification mass spectrometry.

Authors:  Maxim Isabelle; Xavier Moreel; Jean-Philippe Gagné; Michèle Rouleau; Chantal Ethier; Pierre Gagné; Michael J Hendzel; Guy G Poirier
Journal:  Proteome Sci       Date:  2010-04-13       Impact factor: 2.480

8.  Regulation of transcription factor NFAT by ADP-ribosylation.

Authors:  Opeyemi A Olabisi; Noemi Soto-Nieves; Edward Nieves; Teddy T C Yang; Xiaoyong Yang; Raymond Y L Yu; Hee Yun Suk; Fernando Macian; Chi-Wing Chow
Journal:  Mol Cell Biol       Date:  2008-02-25       Impact factor: 4.272

9.  ADP-ribosyl-acceptor hydrolase 3 regulates poly (ADP-ribose) degradation and cell death during oxidative stress.

Authors:  Masato Mashimo; Jiro Kato; Joel Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-04       Impact factor: 11.205

10.  Relative biological effectiveness of fast neutrons for apoptosis in mouse hair follicles.

Authors:  Hae-June Lee; Sung-Ho Kim
Journal:  J Vet Sci       Date:  2007-12       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.